S
Sarah Curran
Researcher at King's College London
Publications - 78
Citations - 7948
Sarah Curran is an academic researcher from King's College London. The author has contributed to research in topics: Autism & Attention deficit hyperactivity disorder. The author has an hindex of 36, co-authored 77 publications receiving 7179 citations. Previous affiliations of Sarah Curran include Sussex Partnership NHS Foundation Trust & Brighton and Sussex Medical School.
Papers
More filters
Journal ArticleDOI
An association analysis of candidate genes on chromosome 15 q11-13 and autism spectrum disorder.
Sarah Curran,John Powell,Benjamin M. Neale,Katharina Dworzynski,Tao Li,Declan G. Murphy,Patrick Bolton +6 more
TL;DR: An association analysis of candidate genes on chromosome 15 q11–13 and autism spectrum disorder and Autism spectrum disorder finds associations between these genes and autism.
Journal ArticleDOI
Mission: not impossible? Candidate gene studies in child psychiatric disorders.
TL;DR: Your mission, should you choose to accept it, is to use the candidate gene approach to find susceptibility genes for child psychiatric disorders, and the most robust of these three findings is the association between the 48-bp VNTR in exon 3 of the dopamine D4 receptor gene and ADHD.
Journal Article
Evidence of association between DRD4 and ADHD with conduct disturbance.
Anita Thapar,Janet Holmes,A Payton,Jennifer H. Barrett,Richard Harrington,P McGuffm,M J Owen,W. E. R. Ollier,M. Gill,Aiveen Kirley,Ziarah Hawi,Michael Fitzgerald,Philip Asherson,Sarah Curran,Jonathan Mill,A Gould,E. Taylor,Lindsey Kent,N. Craddock,Jane Worthington +19 more
Book ChapterDOI
Pharmacogenetics in Psychiatry
Evangelia M. Tsapakis,Sarah Curran,Ruth Ohlsen,Nora S. Vyas,Katherine J. Aitchison,Ann K. Daly +5 more
Journal ArticleDOI
Aripiprazole: A Review of its Use in the Treatment of Irritability Associated with Autistic Disorder Patients Aged 6–17
TL;DR: Four open trials and three case series all show support for aripiprazole in reducing the behavioural symptoms of autism, and pooled data from two eight week trials show that sedation is the most commonly reported adverse event.